MedTrace Logo

Quality of Life Model for Older Patients With AML

NCT04380441 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 206

Last updated 2026-05-18

No results posted yet for this study

Summary

The purpose of this study is to describe the differences in quality of life (QOL) among newly diagnosed patients diagnosed with acute myeloid leukemia (AML) to help design a patient decision-making QOL model for aligning patients' choice of treatment with what matters the most to them.

Conditions

Sponsors & Collaborators

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • H. Lee Moffitt Cancer Center and Research Institute

    lead OTHER

Principal Investigators

  • Sara Tinsley, PhD, APRN · Moffitt Cancer Center

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-08
Primary Completion
2023-11-30
Completion
2027-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04380441 on ClinicalTrials.gov